Litcius/Paper detail

Ruthenium(<scp>ii</scp>) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells

Ming‐Wei Lin, Shan–Shan Zou, Xinxing Liao, Yu Chen, Di‐Qing Luo, Liang‐Nian Ji, Hui Chao

2021Chemical Communications34 citationsDOI

Abstract

Herein, we developed the first Ru(ii) complex-based bioorthogonal two-photon photosensitizers. Through bioorthogonal labelling, they realize effective tumour-specific photodynamic therapy against triple-negative breast cancer cells.

Topics & Concepts

Bioorthogonal chemistryTriple-negative breast cancerPhotodynamic therapyRutheniumChemistryLabellingCancer researchBreast cancerPhotosensitizerCombinatorial chemistryCancerBiochemistryClick chemistryPhotochemistryMedicineCatalysisInternal medicineOrganic chemistryClick Chemistry and ApplicationsNanoplatforms for cancer theranosticsPhotodynamic Therapy Research Studies
Ruthenium(<scp>ii</scp>) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells | Litcius